MARKET

NMRA

NMRA

Neumora Therapeutics Inc
NASDAQ
2.250
-0.025
-1.10%
Opening 10:57 12/05 EST
OPEN
2.270
PREV CLOSE
2.275
HIGH
2.300
LOW
2.245
VOLUME
126.39K
TURNOVER
--
52 WEEK HIGH
11.57
52 WEEK LOW
0.6110
MARKET CAP
382.36M
P/E (TTM)
-1.5377
1D
5D
1M
3M
1Y
5Y
1D
Promising Penny Stocks To Watch In December 2025
Simply Wall St · 3d ago
Neumora upgraded at RBC Capital Markets on obesity, Parkinson's asset
Seeking Alpha · 3d ago
Analyst Sees Value In Neumora's Expanding Obesity And Metabolic Pipeline
Benzinga · 3d ago
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
TipRanks · 3d ago
This Chevron Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Benzinga · 4d ago
Neumora Therapeutics Price Target Raised to $7.00/Share From $4.00 by RBC Capital
Dow Jones · 4d ago
Neumora Therapeutics Raised to Outperform From Sector Perform by RBC Capital
Dow Jones · 4d ago
RBC Capital Upgrades Neumora Therapeutics to Outperform, Raises Price Target to $7
Benzinga · 4d ago
More
About NMRA
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Navacaprant is being investigated in the KOASTAL pivotal Phase 3 program, evaluating navacaprant monotherapy in patients with moderate to severe MDD. The Company's next advanced product candidate is NMRA-511, which is a highly selective, novel antagonist of the vasopressin 1a receptor (V1aR) being developed for the treatment of agitation associated with dementia due to Alzheimer's disease (AD).

Webull offers Neumora Therapeutics Inc stock information, including NASDAQ: NMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NMRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NMRA stock methods without spending real money on the virtual paper trading platform.